CF Montreal pledges rebuild in open letter
Article content
The Major League Soccer club announced Wednesday that it has acquired 21-year-old defender Efrain Morales from Atlanta United in return for US$450,000 in 2025 general allocation money (GAM) and $350,000 in conditional GAM.
Article content
Article content
Atlanta would also retain a percentage of a future transfer involving Morales
Article content
The move came hours after club executives published an open letter to fans that acknowledged the team's shortcomings and stated the club would begin a new chapter rooted in ambition, pride and winning.
Article content
President and CEO Gabriel Gervais, managing director of recruitment and sporting methodology Luca Saputo and managing director of academy strategy and roster management Simone Saputo signed the letter.
Article content
Montreal is currently languishing at the bottom of the MLS with a 3-15-6 record — for 15 points in 24 games — and dropped out of the Canadian Championship with a quarterfinal loss to lower-tier Forge FC of the Canadian Premier League in a bleak season.
Article content
The letter said supporters would see concrete steps toward a rebuild in the upcoming transfer windows. The MLS summer window, which allows clubs to sign players plying their trades in other countries, opens Thursday.
Article content
Montreal had the league's lowest payroll last season. Morales is making $112,019 this year, according to the website Spotrac.com.
Article content
Morales began his professional career in 2020 with Atlanta United 2, where he had three goals and an assist over three USL Championship seasons and three MLS Next Pro seasons.
Article content
He made his MLS debut with Atlanta in a 3-0 victory over the Charlotte Independence in the fourth round of the U.S. Open Cup on May 7, 2024.
Article content
Over two MLS seasons, Morales has played 648 minutes over nine games and picked up one assist. He also played in three U.S. Open Cup games.
Article content
Born in Decatur, Ga., Morales represents Bolivia on the international stage.
Article content
'We have not met the standards we set for ourselves, nor those you have the right to expect. That is why we felt the need to communicate with you directly today.
Article content
We share your dissatisfaction with the Club's results, and it is our responsibility to build a winning team that we can all be proud of.
Article content
That is why we have decided to undertake a rebuild and launch a new chapter at CF Montreal. A chapter based on ambition and pride. A new era with victory at the heart of our sporting ambitions, while also honouring our rich history and the connection with you, our 12th player.
Article content
We know that trust is regained through actions. As such, during the upcoming transfer windows, you will see concrete steps, a committed team, and strong initiatives aimed at rebuilding, together, a Club that deserves your loyalty.'
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 minutes ago
- Globe and Mail
Toyota reports a 37% drop in profit, cuts its forecast due to Trump's tariffs
TOKYO (AP) — Toyota's profit plunged 37% in the April-June quarter, the company said Thursday, cutting its full year earnings forecasts largely because of President Donald Trump's tariffs. The Japanese automaker said it based its report on the assumption that Trump's tariffs on exports from Japan, including autos, would be 12.5% starting this month. As of now they stand at 15%. The world's top automaker also makes vehicles in Mexico and Canada. Toyota's profit in the last quarter totaled 841 billion yen, or $5.7 billion, down from 1.33 trillion yen in the same period the year before. Its quarterly sales rose 3%. The status of those exports is unclear since Mexico and Canada are beneficiaries of the U.S. Mexico Canada Agreement, renegotiated from a 1990s pact during Trump's first term in office, that eliminated most tariffs and trade barriers between the three countries. Toyota Motor Corp.'s April-June profit totaled 841 billion yen ($5.7 billion), down from 1.33 trillion yen in the same period of 2024. Quarterly sales rose 3% to 12 trillion yen ($82 billion). Toyota said the tariffs cost its quarterly operating profit 450 billion yen ($3 billion). Cost reduction efforts and the negative impact of an unfavorable exchange rate also hurt its bottom line. The company, which makes the Camry sedan and Lexus luxury models, forecast a 2.66 trillion yen ($18 billion) profit for the full fiscal year ending in March 2026, down from an earlier forecast for a 3.1 trillion yen ($21 billion) profit. Toyota earned nearly 4.8 trillion yen in the previous fiscal year. 'Despite a challenging external environment, we have continued to make comprehensive investments, as well as improvements such as increased unit sales, cost reductions and expanded value chain profits,' Toyota said in a statement that outlined its efforts to minimize the impact of the tariffs. At the retail level, Toyota sold 2.4 million vehicles globally, with sales growing in Japan, North America and Europe from the previous year, when global retail totaled 2.2 million vehicles. Analysts say Toyota is likely among the worst hit by the tariffs among global companies, even compared with other Japanese automakers.
CBC
an hour ago
- CBC
Developer and housing researcher debate foreign investment in B.C. real estate
Retired UBC geographer David Ley is one of the 27 signatories of a letter sent to the prime minister taking a stance against foreign investment in housing in B.C. On the other hand, Cressey Development Group is a signatory of an open letter asking for restrictions on foreign investment to be lifted. Ley and Cressey's executive vice-president Hani Lammam join us on On The Coast to debate which approach is better.
Globe and Mail
2 hours ago
- Globe and Mail
Amgen Inc. Reports Strong Q2 2025 Financial Results
Amgen Inc ( (AMGN)) has released its Q2 earnings. Here is a breakdown of the information Amgen Inc presented to its investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Amgen Inc., a leading biotechnology company, specializes in developing innovative medicines for serious diseases, including cancer, heart disease, and rare conditions. In its recent earnings report for the second quarter of 2025, Amgen announced a 9% increase in total revenues, reaching $9.2 billion, with product sales also growing by 9%. The company's GAAP earnings per share saw a significant rise of 92%, driven by increased revenues, while non-GAAP EPS rose by 21%. Key products such as Repatha and EVENITY showed strong double-digit sales growth, and the company continued to invest in its research and development programs, including the promising MariTide studies. Looking ahead, Amgen remains focused on sustainable, long-term growth, with a projected revenue range of $35.0 billion to $36.0 billion for the full year 2025, and continued investment in its robust pipeline of innovative treatments.
